Suture Versus Glue (Dermabond) Closure During Cesarean Delivery

Intracuticular Sutures Versus Glue (Dermabond) for Skin Closure After Cesarean Delivery

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02831946

Acronym

SVGCS

Enrollment

100

Registered

2016-07-13

Start date

2016-05-31

Completion date

2018-02-28

Last updated

2016-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive; Band, Suture; Complications

Keywords

skin closure, intracuticular suture, glue (dermabond)

Brief summary

To investigate the effect of intracutaneous suture closure versus Glue (dermabond) closure at cesarean section (CS) on long-term cosmetic and maternal outcome.

Detailed description

Women undergoing planned CS were randomized to either intracutaneous suture closure or glue closure using a 1:1 allocation algorithm. Participants and outcome assessors were blinded to group allocation. Scar evaluation was performed after two months. Primary outcome measures were Patient and Observer Scar Assessment Scale (POSAS) summary scores 2 months after surgery. Secondary outcome measures were, duration of surgery, and development of hematoma, seroma, surgical site infection (SSI) or wound disruption. Data were analyzed according to the intention to treat principle.

Interventions

DEVICEMODIFIED VICRYL PLUS

closing the intra-cuticular layer with MODIFIED VICRYL PLUS suture

DEVICEDERMABOND GLUE

closing the intra-cuticular layer with Dermabond glue

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Pregnant women between 18 and 45 years * Elective cesarian section

Exclusion criteria

* Clinical signs of infection at the time of CS * History of keloids and a medical disorder that could affect wound healing * Hypersensitivity to any of the suture materials used in the protocol * Diabetes mellitus * Disorders requiring chronic corticosteroid use or immunosuppression

Design outcomes

Primary

Measure	Time frame	Description
Patient and Observer Scar Assessment Scale (POSAS)	2 month	Subjective scar rating will be performed using the patient component of the POSAS. The POSAS Scale consists of 2 numerical numeric scales: The Patient Scar Assessment Scale and the Observer Scar Assessment Scale

Secondary

Measure	Time frame	Description
post operative complication	1 month	Development of surgical site infection or wound disruption.

Countries

Israel

Contacts

Primary ContactYair M Daykan, MD

yair.dykan@gmail.com972-542198231

Backup ContactReut Ohana

reut.ohana@clalit.org.il972-9-7471588

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026